Gremese, Elisa
 Distribuzione geografica
Continente #
NA - Nord America 6.637
EU - Europa 5.793
AS - Asia 2.872
SA - Sud America 370
AF - Africa 114
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 20
Totale 15.836
Nazione #
US - Stati Uniti d'America 6.530
IT - Italia 1.084
SG - Singapore 1.051
SE - Svezia 1.034
DE - Germania 1.017
CN - Cina 986
FR - Francia 538
PL - Polonia 493
IE - Irlanda 395
UA - Ucraina 371
BR - Brasile 320
ID - Indonesia 236
GB - Regno Unito 223
IN - India 182
FI - Finlandia 164
RU - Federazione Russa 141
CA - Canada 81
BE - Belgio 74
TR - Turchia 70
HK - Hong Kong 69
CI - Costa d'Avorio 49
AT - Austria 44
NL - Olanda 43
IR - Iran 39
JP - Giappone 39
CZ - Repubblica Ceca 30
SA - Arabia Saudita 29
AU - Australia 28
CH - Svizzera 27
VN - Vietnam 22
ES - Italia 19
MX - Messico 17
PK - Pakistan 17
AR - Argentina 15
PH - Filippine 15
BD - Bangladesh 13
EG - Egitto 13
MA - Marocco 13
EU - Europa 12
IL - Israele 12
IQ - Iraq 12
ZA - Sudafrica 12
CL - Cile 11
GR - Grecia 11
RO - Romania 11
LT - Lituania 10
MY - Malesia 10
KR - Corea 9
TW - Taiwan 9
EE - Estonia 8
JO - Giordania 8
NG - Nigeria 8
TN - Tunisia 8
A2 - ???statistics.table.value.countryCode.A2??? 7
CO - Colombia 7
LV - Lettonia 7
AE - Emirati Arabi Uniti 6
DK - Danimarca 6
PT - Portogallo 6
VE - Venezuela 6
BG - Bulgaria 5
HU - Ungheria 5
LA - Repubblica Popolare Democratica del Laos 5
MD - Moldavia 5
NO - Norvegia 5
TH - Thailandia 5
EC - Ecuador 4
LK - Sri Lanka 4
LU - Lussemburgo 4
NP - Nepal 4
RS - Serbia 4
UZ - Uzbekistan 4
PA - Panama 3
SD - Sudan 3
UY - Uruguay 3
AM - Armenia 2
AZ - Azerbaigian 2
CM - Camerun 2
CR - Costa Rica 2
KE - Kenya 2
MG - Madagascar 2
MK - Macedonia 2
MO - Macao, regione amministrativa speciale della Cina 2
NZ - Nuova Zelanda 2
OM - Oman 2
PE - Perù 2
SC - Seychelles 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
A1 - Anonimo 1
AL - Albania 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
GE - Georgia 1
HR - Croazia 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
Totale 15.829
Città #
Chandler 1.263
Singapore 630
Ashburn 553
Warsaw 461
Dublin 375
Fairfield 244
Jakarta 235
Ann Arbor 234
Wilmington 234
Dearborn 225
Jacksonville 212
San Mateo 204
Rome 193
Woodbridge 193
New York 188
Nanjing 163
Houston 160
Milan 148
Seattle 144
Boston 136
Beijing 133
Cattolica 126
Princeton 111
The Dalles 104
Bremen 96
Moscow 92
Cambridge 82
Chicago 80
Marseille 79
Lawrence 77
Helsinki 73
Los Angeles 70
Brussels 65
Redwood City 63
Hong Kong 62
Munich 58
Pune 52
Abidjan 49
Boardman 49
Izmir 47
North Bergen 47
Nanchang 46
Nuremberg 45
Frankfurt am Main 43
Norwalk 41
London 37
Hangzhou 35
Kunming 33
Redmond 33
Hebei 31
Shanghai 29
Falls Church 27
Guangzhou 27
Lancaster 27
Shenyang 27
Toronto 27
Mountain View 26
Tianjin 24
Brno 23
Düsseldorf 23
Hefei 23
Jiaxing 23
Nürnberg 23
São Paulo 21
Augusta 20
Portsmouth 20
Washington 20
Andover 19
Changsha 19
Falkenstein 19
Kraków 19
Vienna 19
Jinan 17
Leawood 17
Busto Arsizio 16
Kish 16
Ottawa 16
University Park 16
Tokyo 15
Zhengzhou 15
Hyderabad 14
Paris 14
San Diego 14
Palermo 13
Zurich 13
Amsterdam 12
Detroit 12
Santa Maria 12
Dammam 11
Phoenix 11
Simi Valley 11
Council Bluffs 10
Fremont 10
Lauterbourg 10
Naples 10
Brasília 9
Chengdu 9
Delhi 9
Haikou 9
Lappeenranta 9
Totale 9.009
Nome #
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 449
Porphyromonas gingivalis and the pathogenesis of rheumatoid arthritis: analysis of various compartments including the synovial tissue 394
The prognostic significance of the Birmingham Vasculitis Activity Score (BVAS) with systemic vasculitis patients transferred to the intensive care unit (ICU) 328
MicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritis 303
Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis 285
Overweight/obesity affects histological features and inflammatory gene signature of synovial membrane of Rheumatoid Arthritis 275
MicroRNA-155-at the Critical Interface of Innate and Adaptive Immunity in Arthritis. 214
B cell subsets in the joint compartments of seropositive and seronegative RA and non-RA arthritides express memory markers and ZAP-70 and characterize the aggregate pattern irrespectively of the autoantibody status. 202
Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosis. 178
Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis 150
B-cell subsets in the joint compartments of seropositive and seronegative rheumatoid arthritis (RA) and No-RA arthritides express memory markers and ZAP70 and characterize the aggregate pattern irrespectively of the autoantibody status 147
Porphyromonas gingivalis and the pathogenesis of rheumatoid arthritis: analysis of various compartments including the synovial tissue. 145
MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis 144
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 140
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 133
Very early rheumatoid arthritis is the major predictor of major outcome: clinical ACR remission and radiographic non-progression. 131
ZAP-70+ B Cell Subset Influences Response to B Cell Depletion Therapy and Early Repopulation in Rheumatoid Arthritis 129
The role of High-mobility group box protein 1 in collagen antibody-induced arthritis is dependent on Vascular endothelial growth factor. 128
Achievement of sustained deep remission with adalimumab in a patient with both refractory ulcerative colitis and seronegative erosive rheumatoid arthritis 126
Proton pump inhibitors in rheumatic diseases: clinical practice, drug interactions, bone fractures and risk of infections 125
Memory B cell subsets and plasmablasts are lower in early than in long-standing rheumatoid arthritis 122
Detection of bone erosions in early rheumatoid arthritis: 3D ultrasonography versus computed tomography 120
Adult onset Still's disease and pregnancy 120
Allele *2 of the HS1,2A enhancer of the Ig regulatory region associates with rheumatoid arthritis 118
Has shoulder ultrasonography got a predictive value in Polymialgia Rheumatica. In: EULAR. 117
Body weight, gender and response to TNF-α blockers in axial spondyloarthritis 117
An autosomal recessive DNASE1L3-related autoimmune disease with unusual clinical presentation mimicking systemic lupus erythematosus 113
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 111
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 109
Tapering and discontinuation of TNF-α blockers without disease relapse using ultrasonography as a tool to identify patients with rheumatoid arthritis in clinical and histological remission 105
Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: A clue to interpret different chances of relapse after clinical remission? 105
PTPN22 1858C>T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis 101
Chemerin and PEDF are metaflammation-related biomarkers of disease activity and obesity in rheumatoid arthritis 100
Clinical and ultrasonographic remission determines different chances of relapse in early and long standing rheumatoid arthritis. 99
IL COINVOLGIMENTO ARTICOLARE NEL LES: LA FORMA CLASSICA E LA VARIANTE “RHUPUS” 99
Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy 98
Synovial tissue derived characteristics are included in a nomogram for the prediction of treatment response in naïve Rheumatoid Arthritis 96
Haemophilus parasuis (Glaesserella parasuis) as a Potential Driver of Molecular Mimicry and Inflammation in Rheumatoid Arthritis 96
Quantitative and semi-quantitative computed tomography analysis of interstitial lung disease associated with systemic sclerosis: A longitudinal evaluation of pulmonary parenchyma and vessels 93
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 92
Sarilumab use in severe SARS-CoV-2 pneumonia 92
Biomolecular features of inflammation in obese rheumatoid arthritis patients: management considerations 90
Biomarkers of Good EULAR Response to the B Cell Depletion Therapy in All Seropositive Rheumatoid Arthritis Patients: Clues for the Pathogenesis 89
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 89
Body weight, gender and response to TNF-α blockers in axial spondyloarthritis 88
Baseline shoulder ultrasonography is not a predictive marker of response to glucocorticoids in patients with polymyalgia rheumatica: A 12-month followup study 87
Selective Inhibitors of T Cell Receptor Recognition of Antigen–MHC Complexes for Rheumatoid Arthritis 87
Is Citrullination Required for the Presence of Restricted Clonotypes Reacting With Type II Collagen? Comment on the Article by Chemin et al 86
Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression. 86
Five-year survival on infliximab in rheumatoid arthritis patients: analysis from an Italian registry (GISEA) by different calendar years 85
Residual respiratory impairment after COVID-19 pneumonia 85
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort 83
Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus 81
Comparative analysis of synovial inflammation after SARS-CoV-2 infection 81
Psychological Distress After Covid-19 Recovery: Reciprocal Effects With Temperament and Emotional Dysregulation. An Exploratory Study of Patients Over 60 Years of Age Assessed in a Post-acute Care Service 81
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 80
Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study 80
The metabolic syndrome: the crossroads between rheumatoid arthritis and cardiovascular risk 79
Immunosuppressive Therapy (Methotrexate or Cyclophosphamide) in Combination with Corticosteroids in the Treatment of Giant Cell Arteritis: Comparison with Corticosteroids Alone 78
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 78
Systemic Bone Density at Disease Onset Is Associated With Joint Erosion Progression in Early Naive to Treatment Rheumatoid Arthritis: A Prospective 12-Month Follow-Up Open-Label Study 78
Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases) 77
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease 76
Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study 75
Simultaneous onset of mycobacterium kansasii pulmonary infection and systemic lupus erythematosus: A case report 75
Polymorphisms of the IgH enhancer HS1.2 and risk of systemic lupus erythematosus 74
Therapeutic drug monitoring is more cost-effective than a clinically-based approach in the management of loss of response to infliximab in inflammatory bowel disease: an observational multi-centre study. 74
Validation of the classification criteria for cryoglobulinaemic vasculitis 73
CTLA-4 Ig as an effective treatment in a patient with type I diabetes mellitus and seropositive rheumatoid arthritis 73
Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group 73
Association between the response to B cell depletion therapy and the allele*2 of the HS1,2A enhancer in seropositive rheumatoid arthritis patients 72
Adult Onset Still's Disease and Radiotherapy treatment for breast cancer: Case report about management of this rare association and literature review 72
Position paper of Italian rheumatologists on the use of biosimilar drugs 71
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 71
Residual respiratory impairment after COVID-19 pneumonia 69
Body weight, gender and response to TNF-α blockers in axial spondyloarthritis 69
Free light chains of immunoglobulins in patients with systemic sclerosis: correlations with lung involvement and inflammatory milieu 69
Adiposity, joint and systemic inflammation: the additional risk of having a metabolic syndrome in rheumatoid arthritis 68
Rheumatoid arthritis and Alzheimer's disease: genetic and epigenetic links in inflammatory regulation 68
Safety of etanercept and methotrexate in patients with rheumatoid arthritis and hepatitis C virus infection: a multicenter randomized clinical trial 68
CTLA-4 Ig as an effective treatment in a patient with type I diabetes mellitus and seropositive rheumatoid arthritis 68
Comment on: Emergence of severe spondyloarthropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease 68
Checkpoint inhibitors (CPI) and autoimmune chronic inflammatory diseases (ACIDs): tolerance and loss of tolerance in the occurrence of immuno-rheumatologic manifestations 68
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 68
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study 67
Is it necessary to be citrullinated to have restricted clonotypes reacting with Collagen type II? Comment to article "A novel HLA-DRB1*10:01 restricted T cell epitope from citrullinated type II collagen relevant for Rheumatoid Arthritis" 67
An unusual lung involvement in scleroderma: lipoid pneumonia 67
Abatacept in the treatment of psoriatic arthritis: biological and clinical profiles (of the responders). 66
Anti-Müllerian hormone serum levels in systemic lupus erythematosus patients: Influence of the disease severity and therapy on the ovarian reserve 66
Do we need to apply a T2T strategy even in ACPA-negative early rheumatoid arthritis? YES 65
Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy 65
Response to interleukin-1 inhibitors in 140 Italian patients with adult-onset still's disease: A multicentre retrospective observational study 65
Correction to: Anti-Müllerian hormone serum levels in systemic lupus erythematosus patients: influence of the disease severity and therapy on the ovarian reserve (Endocrine, (2019), 63, 2, (369-375), 10.1007/s12020-018-1783-1) 65
Disease-modifying Antirheumatic Drugs (DMARD) and Combination Therapy of Conventional DMARD in Patients with Spondyloarthritis and Psoriatic Arthritis with Axial Involvement 64
Long-term retention rate of anakinra in adult onset Still’s disease and predictive factors for treatment response. 64
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease 64
Weight Loss, The Obesity Paradox in Rheumatoid Arthritis: Is It a Paradox? Comment on the Article by Baker et al 64
Immune-Guided Therapy of COVID-19 64
Malnutrition in COVID-19 survivors: prevalence and risk factors 63
Malnutrition in COVID-19 survivors: prevalence and risk factors 63
Totale 10.698
Categoria #
all - tutte 85.921
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.921


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020269 0 0 0 0 0 0 0 0 0 0 166 103
2020/20211.425 100 111 251 103 147 87 114 21 164 98 187 42
2021/20221.752 198 110 56 104 110 54 40 224 88 127 258 383
2022/20233.992 450 465 354 667 323 508 194 279 445 99 128 80
2023/20242.198 86 546 83 100 89 341 190 88 36 116 288 235
2024/20252.791 100 101 349 172 352 170 181 179 671 450 66 0
Totale 16.169